These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29118487)

  • 1. Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis.
    Al-Amri AM; Fiorentini SF; Albarry MA; Bamahfouz AY
    Oman J Ophthalmol; 2017; 10(3):145-149. PubMed ID: 29118487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus Ointment for Treatment of Vernal Keratoconjunctivitis.
    Al-Amri AM; Mirza AG; Al-Hakami AM
    Middle East Afr J Ophthalmol; 2016; 23(1):135-8. PubMed ID: 26957853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis.
    Kheirkhah A; Zavareh MK; Farzbod F; Mahbod M; Behrouz MJ
    Eye (Lond); 2011 Jul; 25(7):872-80. PubMed ID: 21475312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of low-dose topical tacrolimus in vernal keratoconjunctivitis.
    Shoughy SS; Jaroudi MO; Tabbara KF
    Clin Ophthalmol; 2016; 10():643-7. PubMed ID: 27103784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of topical tacrolimus 0.03% in the management of vernal keratoconjunctivitis: a non-randomized controlled clinical trial.
    Eltagoury M; Abou Samra W; Ghoneim E
    Med Hypothesis Discov Innov Ophthalmol; 2022; 11(2):52-63. PubMed ID: 37641784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis.
    Wan Q; Tang J; Han Y; Wang D; Ye H
    Ophthalmic Res; 2018; 59(3):126-134. PubMed ID: 28803239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis.
    Al-Amri AM
    Am J Ophthalmol; 2014 Feb; 157(2):280-6. PubMed ID: 24439439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus in Corticosteroid-Refractory Vernal Keratoconjunctivitis.
    Chatterjee S; Agrawal D
    Cornea; 2016 Nov; 35(11):1444-1448. PubMed ID: 27310883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East.
    Fiorentini SF; Khurram D
    Saudi J Ophthalmol; 2019; 33(2):117-120. PubMed ID: 31384152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparision of efficacy and safety of 0.03% and 0.1% tacrolimus ointment in children with vernal keratoconjunctivitis.
    Saha BC; Kumari R; Ambasta A
    Ther Adv Ophthalmol; 2023; 15():25158414231173532. PubMed ID: 37255622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of 0.1% Tacrolimus Eye Ointment in Allergic Ocular Diseases.
    Barot RK; Shitole SC; Bhagat N; Patil D; Sawant P; Patil K
    J Clin Diagn Res; 2016 Jun; 10(6):NC05-9. PubMed ID: 27504320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study between ciclosporine A eye drop (2%) and tacrolimus eye ointment (0.03%) in management of children with refractory vernal keratoconjunctivitis.
    Heikal MA; Soliman TT; Abousaif WS; Shebl AA
    Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):353-361. PubMed ID: 34453603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
    Vichyanond P; Pacharn P; Pleyer U; Leonardi A
    Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial.
    Müller EG; Santos MSD; Freitas D; Gomes JÁP; Belfort R
    Arq Bras Oftalmol; 2017 Jun; 80(3):154-158. PubMed ID: 28832739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of 0.05% Azelastine and 0.1% Tacrolimus Eye Drops in Children With Vernal Keratoconjunctivitis: A Prospective Study.
    Chen M; Wei A; Ke B; Zou J; Gong L; Wang Y; Zhang C; Xu J; Yin J; Hong J
    Front Med (Lausanne); 2021; 8():650083. PubMed ID: 34604246
    [No Abstract]   [Full Text] [Related]  

  • 17. Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis.
    Liu FY; Liu HY; Chu HS; Chen WL; Hu FR; Wang IJ
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):967-974. PubMed ID: 30852635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of 0.1% tacrolimus ophthalmic suspension in the treatment of severe atopic keratoconjunctivitis.
    Yazu H; Shimizu E; Aketa N; Dogru M; Okada N; Fukagawa K; Fujishima H
    Ann Allergy Asthma Immunol; 2019 Apr; 122(4):387-392.e1. PubMed ID: 30639466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases.
    Yazu H; Fukagawa K; Shimizu E; Sato Y; Fujishima H
    Allergy Asthma Clin Immunol; 2021 Feb; 17(1):11. PubMed ID: 33522964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vernal keratoconjunctivitis in Thailand.
    Kosrirukvongs P; Vichyanond P; Wongsawad W
    Asian Pac J Allergy Immunol; 2003 Mar; 21(1):25-30. PubMed ID: 12931748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.